Form 8-K - Current report:
SEC Accession No. 0001437749-25-022112
Filing Date
2025-07-03
Accepted
2025-07-03 14:26:36
Documents
19
Period of Report
2025-06-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K wint20250702_8k.htm   iXBRL 8-K 33470
2 EXHIBIT 4.1 ex_836244.htm EX-4.1 111822
3 EXHIBIT 4.2 ex_836246.htm EX-4.2 103134
4 EXHIBIT 4.3 ex_836245.htm EX-4.3 111828
5 EXHIBIT 4.4 ex_836247.htm EX-4.4 103142
6 EXHIBIT 10.1 ex_836248.htm EX-10.1 174633
7 EXHIBIT 10.2 ex_836249.htm EX-10.2 174637
  Complete submission text file 0001437749-25-022112.txt   1131971

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA wint-20250627.xsd EX-101.SCH 3578
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE wint-20250627_def.xml EX-101.DEF 11806
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE wint-20250627_lab.xml EX-101.LAB 15857
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE wint-20250627_pre.xml EX-101.PRE 12021
21 EXTRACTED XBRL INSTANCE DOCUMENT wint20250702_8k_htm.xml XML 2949
Mailing Address 2600 KELLY ROAD SUITE 100 WARRINGTON PA 18976
Business Address 2600 KELLY ROAD SUITE 100 WARRINGTON PA 18976 2154889300
WINDTREE THERAPEUTICS INC /DE/ (Filer) CIK: 0000946486 (see all company filings)

EIN.: 943171943 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39290 | Film No.: 251105078
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)